Minocin
AssetAlso Minocin (minocycline) for Injection
Tetracycline-class broad-spectrum antibiotic that inhibits bacterial protein synthesis.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 140
- Trials
- 1
- Developer
Indications
2Acute renal insufficiency
Phase 1, Terminated, NCT02808052, clinicaltrials.gov, 7 Oct 2026
Chronic renal insufficiency
Phase 1, Terminated, NCT02808052, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials140
- Evidence for its targets1
- Competitors3
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 4 sources